Bioprinted 3D Primary Human Intestinal Tissues Model Aspects of Native Physiology and ADME/Tox Functions

被引:119
作者
Madden, Lauran R. [1 ]
Nguyen, Theresa V. [2 ]
Garcia-Mojica, Salvador [1 ]
Shah, Vishal [1 ]
Le, Alex V. [1 ]
Peier, Andrea [3 ]
Visconti, Richard [3 ]
Parker, Eric M. [3 ]
Presnell, Sharon C. [1 ]
Nguyen, Deborah G. [1 ]
Retting, Kelsey N. [1 ]
机构
[1] Organovo Inc, San Diego, CA 92121 USA
[2] Merck & Co Inc, Dept Pharmacokinet, Rahway, NJ 07065 USA
[3] Merck & Co Inc, Dept Pharmacol, Kenilworth, NJ 07033 USA
关键词
DRUG-METABOLIZING-ENZYMES; CANCER RESISTANCE PROTEIN; PLURIPOTENT STEM-CELLS; IN-VITRO MODEL; P-GLYCOPROTEIN; PRECLINICAL MODELS; CULTURE-SYSTEM; CACO-2; CELLS; DISEASE; PERMEABILITY;
D O I
10.1016/j.isci.2018.03.015
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The human intestinal mucosa is a critical site for absorption, distribution, metabolism, and excretion (ADME)/Tox studies in drug development and is difficult to recapitulate in vitro. Using bioprinting, we generated three-dimensional (3D) intestinal tissue composed of human primary intestinal epithelial cells and myofibroblasts with architecture and function to model the native intestine. The 3D intestinal tissue demonstrates a polarized epithelium with tight junctions and specialized epithelial cell types and expresses functional and inducible CYP450 enzymes. The 3D intestinal tissues develop physiological barrier function, distinguish between high-and low-permeability compounds, and have functional P-gp and BCRP transporters. Biochemical and histological characterization demonstrate that 3D intestinal tissues can generate an injury response to compound-induced toxicity and inflammation. This model is compatible with existing preclinical assays and may be implemented as an additional bridge to clinical trials by enhancing safety and efficacy prediction in drug development.
引用
收藏
页码:156 / +
页数:30
相关论文
共 42 条
  • [11] Organoids as an in vitro model of human development and disease
    Fatehullah, Aliya
    Tan, Si Hui
    Barker, Nick
    [J]. NATURE CELL BIOLOGY, 2016, 18 (03) : 246 - 254
  • [12] Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination
    Jones, Christopher R.
    Hatley, Oliver J. D.
    Ungell, Anna-Lena
    Hilgendorf, Constanze
    Peters, Sheila Annie
    Rostami-Hodjegan, Amin
    [J]. AAPS JOURNAL, 2016, 18 (03): : 589 - 604
  • [13] Alternative functional in vitro models of human intestinal epithelia
    Kauffman, Amanda L.
    Gyurdieva, Alexandra V.
    Mabus, John R.
    Ferguson, Chrissa
    Yan, Zhengyin
    Hornby, Pamela J.
    [J]. FRONTIERS IN PHARMACOLOGY, 2013, 4
  • [14] Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow
    Kim, Hyun Jung
    Huh, Dongeun
    Hamilton, Geraldine
    Ingber, Donald E.
    [J]. LAB ON A CHIP, 2012, 12 (12) : 2165 - 2174
  • [15] Kim RB, 1999, PHARMACEUT RES, V16, P408
  • [16] 3D Proximal Tubule Tissues Recapitulate Key Aspects of Renal Physiology to Enable Nephrotoxicity Testing
    King, Shelby M.
    Higgins, J. William
    Nino, Celina R.
    Smith, Timothy R.
    Paffenroth, Elizabeth H.
    Fairbairn, Casey E.
    Docuyanan, Abigail
    Shah, Vishal D.
    Chen, Alice E.
    Presnell, Sharon C.
    Nguyen, Deborah G.
    [J]. FRONTIERS IN PHYSIOLOGY, 2017, 8
  • [17] Involvement of P-glycoprotein, multidrug resistance protein 2 and breast cancer resistance protein in the transport of belotecan and topotecan in Caco-2 and MDCKII cells
    Li, Hong
    Jin, Hyo-Eon
    Kim, Wooyoung
    Han, Yong-Hae
    Kim, Dae-Duk
    Chung, Suk-Jae
    Shim, Chang-Koo
    [J]. PHARMACEUTICAL RESEARCH, 2008, 25 (11) : 2601 - 2612
  • [18] Precision-cut intestinal slices: alternative model for drug transport, metabolism, and toxicology research
    Li, Ming
    de Graaf, Inge A. M.
    Groothuis, Geny M. M.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (02) : 175 - 190
  • [19] Animal versus human oral drug bioavailability: Do they correlate?
    Musther, Helen
    Olivares-Morales, Andres
    Hatley, Oliver J. D.
    Liu, Bo
    Hodjegan, Amin Rostami
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 57 : 280 - 291
  • [20] New targets for mucosal healing and therapy in inflammatory bowel diseases
    Neurath, M. F.
    [J]. MUCOSAL IMMUNOLOGY, 2014, 7 (01) : 6 - 19